Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin P Trewin

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Opinion in Neurology|June 8, 2022
Immunotherapy in autoimmune encephalitisBenjamin P Trewin, Isaak Freeman, Sudarshini Ramanathan, et al.
Autoimmunity Reviews|November 22, 2024
MOGAD: A comprehensive review of clinicoradiological features, therapy and outcomes in 4699 patients globallyBenjamin P Trewin, Fabienne Brilot, Stephen W Reddel, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 15, 2024
Clinical relapse after 52 years in myelin oligodendrocyte glycoprotein antibody-associated diseaseBenjamin P Trewin, Hanka Laue-Gizzi, John Downie, et al.
Multiple Sclerosis and Related Disorders|May 18, 2020
Precision therapy for neuromyelitis optica spectrum disorder: A retrospective analysis of the use of class-switched memory B-cells for individualised rituximab dosing schedulesBenjamin P Trewin, Stephen Adelstein, Judith M Spies, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 14, 2024
Oral corticosteroid dosage and taper duration at onset in myelin oligodendrocyte glycoprotein antibody-associated disease influences time to first relapseBenjamin P Trewin, Russell C Dale, Jessica Qiu, et al.
Annals of Clinical and Translational Neurology|July 29, 2024
The clinical relevance of MOG antibody testing in cerebrospinal fluidMolly Reynolds, Irene Tan, Kristy Nguyen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 30, 2024
The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-associated diseaseGanesha Liyanage, Benjamin P Trewin, Joseph A Lopez, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Opinion in Neurology|June 8, 2022
Immunotherapy in autoimmune encephalitisBenjamin P Trewin, Isaak Freeman, Sudarshini Ramanathan, et al.
Autoimmunity Reviews|November 22, 2024
MOGAD: A comprehensive review of clinicoradiological features, therapy and outcomes in 4699 patients globallyBenjamin P Trewin, Fabienne Brilot, Stephen W Reddel, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 15, 2024
Clinical relapse after 52 years in myelin oligodendrocyte glycoprotein antibody-associated diseaseBenjamin P Trewin, Hanka Laue-Gizzi, John Downie, et al.
Multiple Sclerosis and Related Disorders|May 18, 2020
Precision therapy for neuromyelitis optica spectrum disorder: A retrospective analysis of the use of class-switched memory B-cells for individualised rituximab dosing schedulesBenjamin P Trewin, Stephen Adelstein, Judith M Spies, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 14, 2024
Oral corticosteroid dosage and taper duration at onset in myelin oligodendrocyte glycoprotein antibody-associated disease influences time to first relapseBenjamin P Trewin, Russell C Dale, Jessica Qiu, et al.
Annals of Clinical and Translational Neurology|July 29, 2024
The clinical relevance of MOG antibody testing in cerebrospinal fluidMolly Reynolds, Irene Tan, Kristy Nguyen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 30, 2024
The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-associated diseaseGanesha Liyanage, Benjamin P Trewin, Joseph A Lopez, et al.
Pageof 1